Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Padcev 30mg Injection
Manufacturer/Marketed By : ASTELLAS PHARMA INC
$1333.22 $1199.90
Sidmex Inovia offers bulk export supply of Padcev 30mg Injection (ENFORTUMAB VEDOTIN) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and...
ENFORTUMAB VEDOTIN
Active Pharmaceutical Ingredient
Padcev 30mg Injection
$1,333.22
$1,199.90
Sidmex Inovia offers bulk export supply of Padcev 30mg Injection (ENFORTUMAB VEDOTIN) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Padcev 30mg Injection contains the active substance Enfortumab vedotin. It is an antineoplastic drug that belongs to the class of antibody-drug conjugates (ADCs). Padcev 30mg Injection is used to treat adults with locally advanced or metastatic urothelial cancer who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy. Padcev Injection works by targeting a protein called Nectin-4, which is highly expressed in urothelial cancer cells. The drug delivers a cytotoxic agent known as monomethyl auristatin E (MMAE) directly to the cancer cells. Once inside the cells, MMAE disrupts the microtubule network, leading to cell cycle arrest and cell death. This targeted mechanism helps to destroy cancer cells while minimising damage to healthy tissues. Do not give Padcev 30mg Injection to children or adolescents under the age of 18. Do not use Padcev 30mg Injection if you are allergic to Enfortumab vedotin or any other ingredients of this medicine. Before starting treatment, inform your doctor if you have a history of kidney problems, heart conditions, eye disorders or if you’ve experienced lung inflammation. Report any symptoms such as difficulty breathing with cough or fever, severe skin peeling, persistent fever, easy bruising or bleeding, unusual tiredness, pale skin, or signs of infection to your healthcare provider promptly. Padcev 30 mg price is based on the seller and the place.
Active Pharmaceutical Ingredient
Uses
• Locally advanced or metastatic urothelial cancer in adult patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Padcev side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.
Most Common Side Effects
• Severe Peripheral Neuropathy: May require padcev enfortumab vedotin dosage adjustment or discontinuation of treatment.
• Serious Skin Reactions: Including conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis; treatment should be stopped immediately if these occur.
• Hyperglycemia: Can result in ketoacidosis or hyperosmolar hyperglycemic state; requires careful monitoring and management.
Common Side Effects
• Fatigue
• Nausea
• Decreased appetite
• Diarrhea
• Rash
• Hair loss (alopecia)
• Altered taste (dysgeusia)
• Dry eyes
How To Use
Treatment with Padcev 30mg Injection should be initiated and supervised by a physician experienced in anti-cancer therapies in a hospital setting, with administration in a healthcare facility equipped to manage potential infusion-related reactions. Padcev Injection is given as an intravenous (IV) infusion under the supervision of a qualified healthcare professional, requiring good venous access before starting treatment. This medication must not be self-administered. Your healthcare Provider will decide the Padcev dosage schedule.
Safety Advice
• Breast Feeding: It is unknown if Padcev 30mg Injection are safe to take during breastfeeding. Please consult your healthcare provider if you have any concerns.
• Alcohol: It is unknown whether alcohol consumption is safe while you are undergoing Padcev 30mg Injection course. It is recommended to consult your doctor for better guidance.
• Liver: If you have any pre-existing liver conditions, discuss them with your doctor before starting treatment with Padcev 30mg Injection.
• Lungs: If you have any pre-existing lung conditions, discuss them with your doctor before starting treatment with Padcev 30mg Injection.
• Driving: It is safe to use Padcev 30mg Injection, as it has no or negligible influence on the ability to drive and use machines. However, if you experience any side effects such as dizziness or blurred vision, consult your doctor before engaging in these activities.
• Pregnancy: It is unsafe to take Padcev 30mg Injection if you are pregnant, as it may cause fetal harm. Consult your doctor for advice and discuss effective contraception methods before starting treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.